Cell Lysis/Cell Fractionation Market by Product (Consumables (Enzymes, Detergent), Instruments (Sonicators)), Cell Type (Mammalian), Application (Protein Purification), End User (Biopharmaceutical & Biotechnology Companies) - Global Forecast to 2026

世界の細胞溶解/細胞分画市場予測:製品別、細胞種類別、用途別、エンドユーザー別

◆タイトル:Cell Lysis/Cell Fractionation Market by Product (Consumables (Enzymes, Detergent), Instruments (Sonicators)), Cell Type (Mammalian), Application (Protein Purification), End User (Biopharmaceutical & Biotechnology Companies) - Global Forecast to 2026
◆商品コード:BT4209
◆調査・発行会社:MarketsandMarkets
◆発行日:2021年3月17日
◆ページ数:167
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:バイオ
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD4,950 ⇒換算¥534,600見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥718,200見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥880,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

マーケッツアンドマーケッツ社は世界の細胞溶解/細胞分画市場規模が2021年29億ドルから2026年41億ドルまで、年平均7.2%成長すると予想しています。本市場調査資料では、細胞溶解/細胞分画の世界市場を広く調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、製品別(消耗品、機器)分析、細胞種類別(哺乳類細胞、微生物細胞、その他細胞)分析、用途別(タンパク質精製・分離、核酸精製・分離、その他)分析、エンドユーザー別(研究所・機関、バイオ医薬品・バイオテクノロジー企業、その他)分析、地域別分析、競争状況、企業情報などを掲載しています。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場概要
・世界の細胞溶解/細胞分画市場規模:製品別(消耗品、機器)
・世界の細胞溶解/細胞分画市場規模:細胞種類別(哺乳類細胞、微生物細胞、その他細胞)
・世界の細胞溶解/細胞分画市場規模:用途別(タンパク質精製・分離、核酸精製・分離、その他)
・世界の細胞溶解/細胞分画市場規模:エンドユーザー別(研究所・機関、バイオ医薬品・バイオテクノロジー企業、その他)
・世界の細胞溶解/細胞分画市場規模:地域別
・競争状況
・企業情報

“The global cell lysis market size is projected to reach USD 4.1 billion by 2026 from USD 2.9 billion in 2021, at a CAGR of 7.2% from 2021 to 2026.”
Growth in this market is driven by the increasing government funding for research, high prevalence of diseases, and growing focus on personalized medicine.

“Consumables segment to witness the highest growth during the forecast period.”
Based on the product, the cell lysis market is segmented into cosumables and insturments. The consumables segment is projected to grow at the highest CAGR during the forecast period. purchase and high consumption, the high prevalence of diseases, and increasing funding for cell-based research are the major factor supporting the growth of this segment.

“Protein purification and isolation segment to register the highest growth in the cell lysis market during the forecast period.”
Based on the application, the cell lysis market is segmented into protein purification and isolation, nucleic acid isolation and purification and other application. The protein purification and isolation segment is projected to witness the highest growth in the cell lysis market during the forecast period. The increasing focus on cell-based research, high demand for protein biologics, and extensive proteomic research are the major factors supporting the growth of this segment.

“Asia Pacific is estimated to register the highest CAGR during the forecast period.”
In this report, the cell lysis market is segmented into four major regional segments, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW). The market in Asia Pacific is projected to register the highest growth rate during the forecast period. The growth in this market is primarily driven by the government support for vaccine production, increasing funding for cell-based research, low manufacturing costs, and the growing focus of global market players on emerging Asian economies.

Breakdown of supply-side primary interviews, by company type, designation, and region:
• By Company Type: Tier 1 (32%) , Tier 2 (44%), and Tier 3 (24%)
• By Designation: C-level (30%), Director-level (34%), and Others (36%)
• By Region: North America (50%), Europe (32%), AsiaPacific (10%), and Rest of the World(8%)

List of Companies Profiled in the Report:
• Thermo Fisher Scientific (US)
• Merck KGaA (Germany)
• Becton, Dickinson and Company (US)
• Danaher Corporation (US)
• Bio-Rad Laboratories (US)
• Cell Signaling Technology Inc. (US)
• Miltenyi Biotec (Germany)
• Roche Diagnostics (Switzerland)
• Qsonica LLC (US)
• Stemcell Technologies (US)
• Promocell (US)
• Agilent Technologies (US)
• NZYTECH (Portugal)
• Takara Bio (Japan)
• Norgen Biotek Corp. (Canada)
• Biovision (US)

Research Coverage:
This report studies the cell lysis market based on product, cell type, application, end user, and region. The report also analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth. It evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total cell lysis market. The report forecasts the revenue of the market segments with respect to four major regions.

Reasons to Buy the Report:
The report provides insights on the following pointers:
• Market Penetration: Comprehensive information on cell lysis products offered by the top 24 players in the cell lysis market. The report analyzes the cell lysis market by product, cell type, application, end user, and region.
• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various securement devices across key geographic regions.
• Market Diversification: Exhaustive information about untapped geographies, recent developments, and investments in the cell lysis market.
• Competitive Assessment: In-depth assessment of market shares and strategies of the leading players in the cell lysis market.

【レポートの目次】

1 INTRODUCTION 25
1.1 OBJECTIVES OF THE STUDY 25
1.2 MARKET DEFINITION 25
1.2.1 INCLUSIONS & EXCLUSIONS 25
1.3 MARKET SCOPE 26
1.3.1 MARKET SEGMENTATION 26
1.3.2 YEARS CONSIDERED FOR THE STUDY 26
1.4 CURRENCY 27
1.5 LIMITATIONS 27
1.6 MARKET STAKEHOLDERS 27
1.7 SUMMARY OF CHANGES 27
2 RESEARCH METHODOLOGY 29
2.1 RESEARCH DATA 29
FIGURE 1 RESEARCH DESIGN 29
2.1.1 SECONDARY DATA 30
2.1.1.1 Secondary sources 30
2.1.2 PRIMARY DATA 31
FIGURE 2 PRIMARY SOURCES 31
2.1.2.1 Key data from primary sources 32
2.1.2.2 Key industry insights 32
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE,
DESIGNATION, AND REGION 33
2.2 MARKET SIZE ESTIMATION 33
FIGURE 4 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 33
FIGURE 5 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH (APPLICATION-BASED) 34
FIGURE 6 TOP-DOWN APPROACH 35
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 36
FIGURE 7 DATA TRIANGULATION METHODOLOGY 36
2.4 ASSUMPTIONS FOR THE STUDY 37
3 EXECUTIVE SUMMARY 38
FIGURE 8 CELL LYSIS MARKET, BY PRODUCT, 2021 VS. 2026 (USD MILLION) 38
FIGURE 9 CELL LYSIS MARKET, BY CELL TYPE, 2021 VS. 2026 (USD MILLION) 39
FIGURE 10 CELL LYSIS MARKET, BY APPLICATION, 2021 VS. 2026 (USD MILLION) 39
FIGURE 11 CELL LYSIS MARKET, BY END USER, 2021 VS. 2026 (USD MILLION) 40
FIGURE 12 CELL LYSIS MARKET, BY REGION, 2021 VS. 2026 (USD MILLION) 40

4 PREMIUM INSIGHTS 42
4.1 CELL LYSIS MARKET OVERVIEW 42
FIGURE 13 INCREASING FOCUS ON PERSONALIZED MEDICINE DRIVES
THE GROWTH OF THE MARKET 42
4.2 CELL LYSIS MARKET, BY PRODUCT 42
FIGURE 14 CONSUMABLES DOMINATE THE PRODUCTS MARKET 42
4.3 NORTH AMERICA: CELL LYSIS MARKET, BY PRODUCT, 2020 43
FIGURE 15 US DOMINATED THE CELL LYSIS MARKET IN 2020 43
4.4 GEOGRAPHICAL SNAPSHOT OF THE CELL LYSIS MARKET 43
FIGURE 16 CHINA TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD 43
5 MARKET OVERVIEW 44
5.1 INTRODUCTION 44
5.2 MARKET DYNAMICS 44
FIGURE 17 CELL LYSIS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 44
5.2.1 DRIVERS 44
5.2.1.1 Increasing government funding for research 44
FIGURE 18 NIH FUNDING, BY RESEARCH AREA, 2016–2021 (USD MILLION) 45
5.2.1.2 High prevalence of diseases 45
TABLE 1 RISING INCIDENCES OF DISEASES 46
5.2.1.3 Growing focus on personalized medicine 46
FIGURE 19 RISING NUMBER OF PERSONALIZED MEDICINES, 2008–2020 46
5.2.2 RESTRAINTS 47
5.2.2.1 High cost of cell-based research and instruments 47
5.2.3 OPPORTUNITIES 47
5.2.3.1 Emerging countries 47
5.2.4 CHALLENGES 47
5.2.4.1 Survival of small players and new entrants 47
5.3 COVID-19 IMPACT ANALYSIS 48
5.4 VALUE CHAIN ANALYSIS 48
FIGURE 20 MAJOR VALUE IS ADDED DURING THE MANUFACTURING & ASSEMBLY PHASE 49
5.5 SUPPLY CHAIN ANALYSIS 49
FIGURE 21 DISTRIBUTION—A STRATEGY PREFERRED BY PROMINENT COMPANIES 50
5.6 ECOSYSTEM ANALYSIS OF THE CELL LYSIS MARKET 50
FIGURE 22 ECOSYSTEM ANALYSIS OF THE CELL LYSIS MARKET 50
5.7 PRICING ANALYSIS 51
TABLE 2 PRICES OF CELL LYSIS PRODUCTS 51
5.8 PORTER’S FIVE FORCES ANALYSIS 51
5.8.1 THREAT FROM NEW ENTRANTS 51
5.8.2 INTENSITY OF COMPETITIVE RIVALRY 51
5.8.3 BARGAINING POWER OF BUYERS 52
5.8.4 BARGAINING POWER OF SUPPLIERS 52
5.8.5 THREAT FROM SUBSTITUTES 52
5.9 TECHNOLOGY ANALYSIS 52
5.10 PATENT ANALYSIS 52
5.11 REGULATORY OUTLOOK 53
5.12 TRADE ANALYSIS 53
5.12.1 TRADE ANALYSIS FOR HOMOGENIZERS 53
TABLE 3 EXPORT DATA FOR HOMOGENIZERS, BY COUNTRY, 2016—2020 (USD MILLION) 53
TABLE 4 IMPORT DATA FOR HOMOGENIZERS, BY COUNTRY, 2016—2020 (USD MILLION) 54
6 CELL LYSIS MARKET, BY PRODUCT 55
6.1 INTRODUCTION 56
TABLE 5 CELL LYSIS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 56
6.2 CONSUMABLES 56
TABLE 6 CELL LYSIS CONSUMABLES MARKET, BY REGION,
2019–2026 (USD MILLION) 56
TABLE 7 CELL LYSIS CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION) 57
6.2.1 REAGENTS & KITS 57
TABLE 8 CELL LYSIS REAGENTS & KITS MARKET, BY REGION,
2019–2026 (USD MILLION) 57
TABLE 9 CELL LYSIS REAGENTS & KITS MARKET, BY TYPE, 2019–2026 (USD MILLION) 57
6.2.1.1 Enzymes 58
6.2.1.1.1 Enzymes dominated the reagents & kits market in 2020 58
TABLE 10 CELL LYSIS ENZYMES MARKET, BY REGION, 2019–2026 (USD MILLION) 58
6.2.1.2 Detergent solutions 58
6.2.1.2.1 Growing research in cell biology is a key factor driving market growth 58
TABLE 11 CELL LYSIS DETERGENT SOLUTIONS MARKET, BY REGION,
2019–2026 (USD MILLION) 59
6.2.1.3 Other reagents & kits 59
TABLE 12 OTHER CELL LYSIS REAGENTS & KITS MARKET, BY REGION,
2019–2026 (USD MILLION) 59
6.2.2 BEADS 60
6.2.2.1 Increasing investments in cell-based research form a major growth factor in this market 60
TABLE 13 CELL LYSIS BEADS MARKET, BY REGION, 2019–2026 (USD MILLION) 60
6.2.3 DISPOSABLES 60
6.2.3.1 North America to show the highest demand for cell lysis disposables 60
TABLE 14 CELL LYSIS DISPOSABLES MARKET, BY REGION, 2019–2026 (USD MILLION) 61
6.3 INSTRUMENTS 61
TABLE 15 CELL LYSIS INSTRUMENTS MARKET, BY REGION, 2019–2026 (USD MILLION) 61
TABLE 16 CELL LYSIS INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 62
6.3.1 SONICATORS 62
6.3.1.1 Sonicators accounted for the largest share of the instruments market in 2020 62
TABLE 17 CELL LYSIS SONICATORS MARKET, BY REGION, 2019–2026 (USD MILLION) 62
6.3.2 HOMOGENIZERS 62
6.3.2.1 Investments in research and technological advancements drive market growth 62
TABLE 18 CELL LYSIS HOMOGENIZERS MARKET, BY REGION,
2019–2026 (USD MILLION) 63
6.3.3 OTHER INSTRUMENTS 63
TABLE 19 OTHER CELL LYSIS INSTRUMENTS MARKET, BY REGION,
2019–2026 (USD MILLION) 63
7 CELL LYSIS MARKET, BY CELL TYPE 64
7.1 INTRODUCTION 65
TABLE 20 CELL LYSIS MARKET, BY CELL TYPE, 2019–2026 (USD MILLION) 65
7.2 MAMMALIAN CELLS 65
7.2.1 MAMMALIAN CELLS TO DOMINATE THE CELL LYSIS MARKET 65
TABLE 21 CELL LYSIS MARKET FOR MAMMALIAN CELLS, BY REGION,
2019–2026 (USD MILLION) 66
7.3 MICROBIAL CELLS 66
7.3.1 INCREASING INVESTMENT ON BIOPHARMACEUTICAL R&D TO DRIVE MARKET GROWTH 66
TABLE 22 CELL LYSIS MARKET FOR MICROBIAL CELLS, BY REGION,
2019–2026 (USD MILLION) 67
7.4 OTHER CELLS 67
TABLE 23 CELL LYSIS MARKET FOR OTHER CELLS, BY REGION,
2019–2026 (USD MILLION) 67
8 CELL LYSIS MARKET, BY APPLICATION 68
8.1 INTRODUCTION 69
TABLE 24 CELL LYSIS MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 69
8.2 PROTEIN PURIFICATION & ISOLATION 69
8.2.1 PROTEIN PURIFICATION AND ISOLATION TO DOMINATE THE CELL LYSIS MARKET DURING THE FORECAST PERIOD 69
TABLE 25 CELL LYSIS MARKET FOR PROTEIN PURIFICATION & ISOLATION, BY REGION, 2019–2026 (USD MILLION) 70
8.3 NUCLEIC ACID PURIFICATION & ISOLATION 70
8.3.1 INCREASING INVESTMENT IN BIOPHARMACEUTICAL R&D TO DRIVE MARKET GROWTH 70
TABLE 26 CELL LYSIS MARKET FOR NUCLEIC ACID ISOLATION & PURIFICATION,
BY REGION, 2019–2026 (USD MILLION) 70
8.4 OTHER APPLICATIONS 71
TABLE 27 CELL LYSIS MARKET FOR OTHER APPLICATIONS, BY REGION,
2019–2026 (USD MILLION) 71
9 CELL LYSIS MARKET, BY END USER 72
9.1 INTRODUCTION 73
TABLE 28 CELL LYSIS MARKET, BY END USER, 2019–2026 (USD MILLION) 73
9.2 RESEARCH LABORATORIES & INSTITUTES 73
9.2.1 RISING RESEARCH FUNDING SUPPORTS MARKET GROWTH 73
TABLE 29 CELL LYSIS MARKET FOR RESEARCH LABORATORIES & INSTITUTES,
BY REGION, 2019–2026 (USD MILLION) 74
9.3 BIOPHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 74
9.3.1 RISING INVESTMENTS IN CELL-BASED RESEARCH AND THERAPY DEVELOPMENT WILL DRIVE MARKET GROWTH 74
TABLE 30 CELL LYSIS MARKET FOR BIOPHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2019–2026 (USD MILLION) 74
9.4 OTHER END USERS 75
TABLE 31 CELL LYSIS MARKET FOR OTHER END USERS, BY REGION,
2019–2026 (USD MILLION) 75
10 CELL LYSIS MARKET, BY REGION 76
10.1 INTRODUCTION 77
TABLE 32 CELL LYSIS MARKET, BY REGION, 2019–2026 (USD MILLION) 77
10.2 NORTH AMERICA 77
FIGURE 23 NORTH AMERICA: MARKET SNAPSHOT 78
TABLE 33 NORTH AMERICA: CELL LYSIS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 78
TABLE 34 NORTH AMERICA: CELL LYSIS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 79
TABLE 35 NORTH AMERICA: CELL LYSIS CONSUMABLES MARKET, BY TYPE,
2019–2026 (USD MILLION) 79
TABLE 36 NORTH AMERICA: CELL LYSIS REAGENTS & KITS MARKET, BY TYPE,
2019–2026 (USD MILLION) 79
TABLE 37 NORTH AMERICA: CELL LYSIS INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 80
TABLE 38 NORTH AMERICA: CELL LYSIS MARKET, BY CELL TYPE,
2019–2026 (USD MILLION) 80
TABLE 39 NORTH AMERICA: CELL LYSIS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 80
TABLE 40 NORTH AMERICA: CELL LYSIS MARKET, BY END USER,
2019–2026 (USD MILLION) 81
10.2.1 US 81
10.2.1.1 The US dominates the market for cell lysis 81
TABLE 41 US: CELL LYSIS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 82
TABLE 42 US: CELL LYSIS CONSUMABLES MARKET, BY TYPE,
2019–2026 (USD MILLION) 82
TABLE 43 US: CELL LYSIS REAGENTS & KITS MARKET, BY TYPE,
2019–2026 (USD MILLION) 82
TABLE 44 US: CELL LYSIS INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 82
TABLE 45 US: CELL LYSIS MARKET, BY CELL TYPE, 2019–2026 (USD MILLION) 83
TABLE 46 US: CELL LYSIS MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 83
TABLE 47 US: CELL LYSIS MARKET, BY END USER, 2019–2026 (USD MILLION) 83
10.2.2 CANADA 84
10.2.2.1 The strong and growing biopharmaceutical and biotechnology sector indicates a favorable outlook for cell lysis 84
TABLE 48 CANADA: CELL LYSIS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 84
TABLE 49 CANADA: CELL LYSIS CONSUMABLES MARKET, BY TYPE,
2019–2026 (USD MILLION) 84
TABLE 50 CANADA: CELL LYSIS REAGENTS & KITS MARKET, BY TYPE,
2019–2026 (USD MILLION) 85
TABLE 51 CANADA: CELL LYSIS INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 85
TABLE 52 CANADA: CELL LYSIS MARKET, BY CELL TYPE, 2019–2026 (USD MILLION) 85
TABLE 53 CANADA: CELL LYSIS MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 86
TABLE 54 CANADA: CELL LYSIS MARKET, BY END USER, 2019–2026 (USD MILLION) 86
10.3 EUROPE 86
TABLE 55 EUROPE: CELL LYSIS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 87
TABLE 56 EUROPE: CELL LYSIS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 87
TABLE 57 EUROPE: CELL LYSIS CONSUMABLES MARKET, BY TYPE,
2019–2026 (USD MILLION) 87
TABLE 58 EUROPE: CELL LYSIS REAGENTS & KITS MARKET, BY TYPE,
2019–2026 (USD MILLION) 88
TABLE 59 EUROPE: CELL LYSIS INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 88
TABLE 60 EUROPE: CELL LYSIS MARKET, BY CELL TYPE, 2019–2026 (USD MILLION) 88
TABLE 61 EUROPE: CELL LYSIS MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 89
TABLE 62 EUROPE: CELL LYSIS MARKET, BY END USER, 2019–2026 (USD MILLION) 89
10.3.1 GERMANY 89
10.3.1.1 Germany dominated the European cell lysis market in 2020 89
TABLE 63 GERMANY: CELL LYSIS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 90
TABLE 64 GERMANY: CELL LYSIS CONSUMABLES MARKET, BY TYPE,
2019–2026 (USD MILLION) 90
TABLE 65 GERMANY: CELL LYSIS REAGENTS & KITS MARKET, BY TYPE,
2019–2026 (USD MILLION) 90
TABLE 66 GERMANY: CELL LYSIS INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 90
TABLE 67 GERMANY: CELL LYSIS MARKET, BY CELL TYPE, 2019–2026 (USD MILLION) 91
TABLE 68 GERMANY: CELL LYSIS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 91
TABLE 69 GERMANY: CELL LYSIS MARKET, BY END USER, 2019–2026 (USD MILLION) 91
10.3.2 UK 92
10.3.2.1 Government initiatives to support market growth 92
TABLE 70 UK: CELL LYSIS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 92
TABLE 71 UK: CELL LYSIS CONSUMABLES MARKET, BY TYPE,
2019–2026 (USD MILLION) 92
TABLE 72 UK: CELL LYSIS REAGENTS & KITS MARKET, BY TYPE,
2019–2026 (USD MILLION) 93
TABLE 73 UK: CELL LYSIS INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 93
TABLE 74 UK: CELL LYSIS MARKET, BY CELL TYPE, 2019–2026 (USD MILLION) 93
TABLE 75 UK: CELL LYSIS MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 94
TABLE 76 UK: CELL LYSIS MARKET, BY END USER, 2019–2026 (USD MILLION) 94
10.3.3 FRANCE 94
10.3.3.1 Increasing R&D investment by players to support market growth 94
TABLE 77 FRANCE: CELL LYSIS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 94
TABLE 78 FRANCE: CELL LYSIS CONSUMABLES MARKET, BY TYPE,
2019–2026 (USD MILLION) 95
TABLE 79 FRANCE: CELL LYSIS REAGENTS & KITS MARKET, BY TYPE,
2019–2026 (USD MILLION) 95
TABLE 80 FRANCE: CELL LYSIS INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 95
TABLE 81 FRANCE: CELL LYSIS MARKET, BY CELL TYPE, 2019–2026 (USD MILLION) 96
TABLE 82 FRANCE: CELL LYSIS MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 96
TABLE 83 FRANCE: CELL LYSIS MARKET, BY END USER, 2019–2026 (USD MILLION) 96
10.3.4 ITALY 96
10.3.4.1 Large life science research base and rising awareness support the market in Italy 96
TABLE 84 ITALY: CELL LYSIS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 97
TABLE 85 ITALY: CELL LYSIS CONSUMABLES MARKET, BY TYPE,
2019–2026 (USD MILLION) 97
TABLE 86 ITALY: CELL LYSIS REAGENTS & KITS MARKET, BY TYPE,
2019–2026 (USD MILLION) 98
TABLE 87 ITALY: CELL LYSIS INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 98
TABLE 88 ITALY: CELL LYSIS MARKET, BY CELL TYPE, 2019–2026 (USD MILLION) 98
TABLE 89 ITALY: CELL LYSIS MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 99
TABLE 90 ITALY: CELL LYSIS MARKET, BY END USER, 2019–2026 (USD MILLION) 99
10.3.5 SPAIN 99
10.3.5.1 Increasing private and public funding to boost the market growth 99
TABLE 91 SPAIN: CELL LYSIS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 100
TABLE 92 SPAIN: CELL LYSIS CONSUMABLES MARKET, BY TYPE,
2019–2026 (USD MILLION) 100
TABLE 93 SPAIN: CELL LYSIS REAGENTS & KITS MARKET, BY TYPE,
2019–2026 (USD MILLION) 100
TABLE 94 SPAIN: CELL LYSIS INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 100
TABLE 95 SPAIN: CELL LYSIS MARKET, BY CELL TYPE, 2019–2026 (USD MILLION) 101
TABLE 96 SPAIN: CELL LYSIS MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 101
TABLE 97 SPAIN: CELL LYSIS MARKET, BY END USER, 2019–2026 (USD MILLION) 101

10.3.6 REST OF EUROPE 101
TABLE 98 ROE: CELL LYSIS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 102
TABLE 99 ROE: CELL LYSIS CONSUMABLES MARKET, BY TYPE,
2019–2026 (USD MILLION) 102
TABLE 100 ROE: CELL LYSIS REAGENTS & KITS MARKET, BY TYPE,
2019–2026 (USD MILLION) 102
TABLE 101 ROE: CELL LYSIS INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 103
TABLE 102 ROE: CELL LYSIS MARKET, BY CELL TYPE, 2019–2026 (USD MILLION) 103
TABLE 103 ROE: CELL LYSIS MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 103
TABLE 104 ROE: CELL LYSIS MARKET, BY END USER, 2019–2026 (USD MILLION) 104
10.4 ASIA PACIFIC 104
FIGURE 24 ASIA PACIFIC: CELL LYSIS MARKET SNAPSHOT 105
TABLE 105 ASIA PACIFIC: CELL LYSIS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 105
TABLE 106 ASIA PACIFIC: CELL LYSIS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 106
TABLE 107 ASIA PACIFIC: CELL LYSIS CONSUMABLES MARKET, BY TYPE,
2019–2026 (USD MILLION) 106
TABLE 108 ASIA PACIFIC: CELL LYSIS REAGENTS & KITS MARKET, BY TYPE,
2019–2026 (USD MILLION) 106
TABLE 109 ASIA PACIFIC: CELL LYSIS INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 107
TABLE 110 ASIA PACIFIC: CELL LYSIS MARKET, BY CELL TYPE,
2019–2026 (USD MILLION) 107
TABLE 111 ASIA PACIFIC: CELL LYSIS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 107
TABLE 112 ASIA PACIFIC: CELL LYSIS MARKET, BY END USER,
2019–2026 (USD MILLION) 108
10.4.1 CHINA 108
10.4.1.1 China to grow at the highest CAGR in the cell lysis market 108
TABLE 113 CHINA: CELL LYSIS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 109
TABLE 114 CHINA: CELL LYSIS CONSUMABLES MARKET, BY TYPE,
2019–2026 (USD MILLION) 109
TABLE 115 CHINA: CELL LYSIS REAGENTS & KITS MARKET, BY TYPE,
2019–2026 (USD MILLION) 109
TABLE 116 CHINA: CELL LYSIS INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 109
TABLE 117 CHINA: CELL LYSIS MARKET, BY CELL TYPE, 2019–2026 (USD MILLION) 110
TABLE 118 CHINA: CELL LYSIS MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 110
TABLE 119 CHINA: CELL LYSIS MARKET, BY END USER, 2019–2026 (USD MILLION) 110
10.4.2 JAPAN 111
10.4.2.1 Rising geriatric population and support for research drive market growth in Japan 111
TABLE 120 JAPAN: CELL LYSIS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 111
TABLE 121 JAPAN: CELL LYSIS CONSUMABLES MARKET, BY TYPE,
2019–2026 (USD MILLION) 111
TABLE 122 JAPAN: CELL LYSIS REAGENTS & KITS MARKET, BY TYPE,
2019–2026 (USD MILLION) 112
TABLE 123 JAPAN: CELL LYSIS INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 112
TABLE 124 JAPAN: CELL LYSIS MARKET, BY CELL TYPE, 2019–2026 (USD MILLION) 112
TABLE 125 JAPAN: CELL LYSIS MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 113
TABLE 126 JAPAN: CELL LYSIS MARKET, BY END USER, 2019–2026 (USD MILLION) 113
10.4.3 INDIA 113
10.4.3.1 Increasing government initiatives on precision medicine will boost the market growth 113
TABLE 127 INDIA: CELL LYSIS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 114
TABLE 128 INDIA: CELL LYSIS CONSUMABLES MARKET, BY TYPE,
2019–2026 (USD MILLION) 114
TABLE 129 INDIA: CELL LYSIS REAGENTS & KITS MARKET, BY TYPE,
2019–2026 (USD MILLION) 114
TABLE 130 INDIA: CELL LYSIS INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 115
TABLE 131 INDIA: CELL LYSIS MARKET, BY CELL TYPE, 2019–2026 (USD MILLION) 115
TABLE 132 INDIA: CELL LYSIS MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 115
TABLE 133 INDIA: CELL LYSIS MARKET, BY END USER, 2019–2026 (USD MILLION) 116
10.4.4 ROAPAC 116
TABLE 134 ROAPAC: CELL LYSIS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 117
TABLE 135 ROAPAC: CELL LYSIS CONSUMABLES MARKET, BY TYPE,
2019–2026 (USD MILLION) 117
TABLE 136 ROAPAC: CELL LYSIS REAGENTS & KITS MARKET, BY TYPE,
2019–2026 (USD MILLION) 117
TABLE 137 ROAPAC: CELL LYSIS INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 118
TABLE 138 ROAPAC: CELL LYSIS MARKET, BY CELL TYPE, 2019–2026 (USD MILLION) 118
TABLE 139 ROAPAC: CELL LYSIS MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 118
TABLE 140 ROAPAC: CELL LYSIS MARKET, BY END USER, 2019–2026 (USD MILLION) 119
10.5 ROW 119
TABLE 141 ROW: CELL LYSIS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 120
TABLE 142 ROW: CELL LYSIS CONSUMABLES MARKET, BY TYPE,
2019–2026 (USD MILLION) 120
TABLE 143 ROW: CELL LYSIS REAGENTS & KITS MARKET, BY TYPE,
2019–2026 (USD MILLION) 120
TABLE 144 ROW: CELL LYSIS INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 120
TABLE 145 ROW: CELL LYSIS MARKET, BY CELL TYPE, 2019–2026 (USD MILLION) 121
TABLE 146 ROW: CELL LYSIS MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 121
TABLE 147 ROW: CELL LYSIS MARKET, BY END USER, 2019–2026 (USD MILLION) 121

11 COMPETITIVE LANDSCAPE 122
11.1 OVERVIEW 122
FIGURE 25 KEY DEVELOPMENTS IN THE CELL LYSIS MARKET,
JANUARY 2018– FEBRUARY 2021 122
FIGURE 26 MARKET EVOLUTION MATRIX: JANUARY 2018 TO JANUARY 2021 123
11.2 MARKET SHARE ANALYSIS 123
FIGURE 27 CELL LYSIS MARKET SHARE ANALYSIS, 2019 123
11.3 COMPANY EVALUATION MATRIX 124
11.3.1 STARS 124
11.3.2 EMERGING LEADERS 124
11.3.3 PERVASIVE PLAYERS 124
11.3.4 PARTICIPANTS 124
FIGURE 28 VENDOR DIVE: CELL LYSIS MARKET 125
11.4 COMPETITIVE LEADERSHIP MAPPING (SMES/ START-UPS) 125
11.4.1 PROGRESSIVE COMPANIES 125
11.4.2 STARTING BLOCKS 126
11.4.3 RESPONSIVE COMPANIES 126
11.4.4 DYNAMIC COMPANIES 126
FIGURE 29 VENDOR DIVE MATRIX FOR SMES & START-UPS: CELL LYSIS MARKET 126
11.5 COMPETITIVE SCENARIO 127
11.5.1 EXPANSIONS 127
TABLE 148 KEY EXPANSIONS, JANUARY 2018–FEBRUARY 2021 127
11.5.2 DEALS 127
TABLE 149 KEY DEALS, JANUARY 2018–FEBRUARY 2021 127
11.5.3 OTHER DEVELOPMENTS 128
TABLE 150 OTHER KEY DEVELOPMENTS, JANUARY 2018–FEBRUARY 2021 128
11.6 COMPANY PRODUCT FOOTPRINT 128
FIGURE 30 PRODUCT PORTFOLIO ANALYSIS: CELL LYSIS MARKET 128
11.7 COMPANY GEOGRAPHIC FOOTPRINT 129
FIGURE 31 GEOGRAPHIC ASSESSMENT: CELL LYSIS MARKET 129
12 COMPANY PROFILES 130
(Business Overview, Products Offered, Recent Developments, and MnM View)*
12.1 KEY PLAYERS 130
12.1.1 THERMO FISHER SCIENTIFIC 130
FIGURE 32 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2019) 130
12.1.2 MERCK 133
FIGURE 33 MERCK KGAA: COMPANY SNAPSHOT (2019) 133
12.1.3 BIO-RAD LABORATORIES 136
FIGURE 34 BIO-RAD LABORATORIES: COMPANY SNAPSHOT (2019) 136
12.1.4 BECKMAN COULTER 138
FIGURE 35 DANAHER CORPORATION: COMPANY SNAPSHOT (2019) 138
12.1.5 BECTON, DICKINSON AND COMPANY 140
FIGURE 36 BD: COMPANY SNAPSHOT (2020) 140
12.1.6 CELL SIGNALING TECHNOLOGY 142
12.1.7 MILTENYI BIOTEC 143
12.1.8 ROCHE DIAGNOSTICS 144
FIGURE 37 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2019) 144
12.1.9 QIAGEN 146
FIGURE 38 QIAGEN: COMPANY SNAPSHOT (2019) 146
12.1.10 QSONICA 148
12.1.11 STEMCELL TECHNOLOGIES 149
12.1.12 PROMOCELL 150
12.1.13 AGILENT TECHNOLOGIES 151
FIGURE 39 AGILENT TECHNOLOGIES: COMPANY SNAPSHOT (2019) 151
12.1.14 PROMEGA CORPORATION 153
12.2 OTHER PLAYERS 154
12.2.1 NZYTECH 154
12.2.2 TAKARA BIO 155
FIGURE 40 TAKARA BIO: COMPANY SNAPSHOT (2020) 155
12.2.3 LABFREEZ INSTRUMENTS GROUP 157
12.2.4 G-BIOSCIENCES (GENO TECHNOLOGY) 158
12.2.5 COVARIS 159
12.2.6 CLAREMONT BIOSOLUTIONS 160
12.2.7 MICROFLUIDICS INTERNATIONAL CORPORATION 161
12.2.8 PARR INSTRUMENT COMPANY 162
12.2.9 BIOVISION 163
12.2.10 NORGEN BIOTEK CORP. 164
*Details on Business Overview, Products Offered, Recent Developments, and MnM View might not be captured in case of unlisted companies.
13 APPENDIX 165
13.1 INSIGHTS OF INDUSTRY EXPERTS 165
13.2 DISCUSSION GUIDE 165
13.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 169
13.4 AVAILABLE CUSTOMIZATIONS 171
13.5 RELATED REPORTS 171
13.6 AUTHOR DETAILS 172



【免責事項】
※当レポート上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当レポートに記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当レポート上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

[世界の細胞溶解/細胞分画市場予測:製品別、細胞種類別、用途別、エンドユーザー別]についてメールでお問い合わせはこちら


◆H&Iグローバルリサーチ株式会社のお客様(例)◆